BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 17725275)

  • 1. [Interleukin-12, vascular endothelial growth factor and tumor necrosis factor-alpha in the process of neoangiogenesis of diabetic retinopathy in children].
    Zorena K; Myśliwska J; Myśliwiec M; Balcerska A; Lipowski P; Raczyńska K
    Klin Oczna; 2007; 109(4-6):155-9. PubMed ID: 17725275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy.
    Myśliwiec M; Balcerska A; Zorena K; Myśliwska J; Lipowski P; Raczyńska K
    Diabetes Res Clin Pract; 2008 Jan; 79(1):141-6. PubMed ID: 17716775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-12 and tumour necrosis factor-alpha equilibrium is a prerequisite for clinical course free from late complications in children with type 1 diabetes mellitus.
    Zorena K; Myśliwska J; Myśliwiec M; Balcerska A; Lipowski P; Raczyńska K
    Scand J Immunol; 2008 Feb; 67(2):204-8. PubMed ID: 18201373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
    Gustavsson C; Agardh E; Bengtsson B; Agardh CD
    J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activity of N-acetyl-beta-D-glucosaminidase and tumor necrosis factor-alpha at early stage of diabetic retinopathy development in type 1 diabetes mellitus children.
    Myśliwiec M; Zorena K; Balcerska A; Myśliwska J; Lipowski P; Raczyńska K
    Clin Biochem; 2006 Aug; 39(8):851-6. PubMed ID: 16696964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells.
    Makino N; Maeda T; Sugano M; Satoh S; Watanabe R; Abe N
    J Diabetes Complications; 2005; 19(6):347-55. PubMed ID: 16260352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
    Adamiec J; Oficjalska-Młyńczak J
    Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The assessment of the correlation between vascular endothelial growth factor (VEGF), tumor necrosis factor (TNF-alpha), interleukin 6 (IL-6), glycaemic control (HbA1c) and the development of the diabetic retinopathy in children with diabetes mellitus type 1].
    Myśliwiec M; Balcerska A; Zorena K; Myśliwska J; Lipowski P; Raczyńska K
    Klin Oczna; 2007; 109(4-6):150-4. PubMed ID: 17725274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
    Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H; Shi CH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interleukin 12 as an anti-angiogenic mediator in type 1 diabetic children].
    Zorena K; Myśliwska J; Myśliwiec M; Balcerska A; Lipowski P; Raczyńska K
    Pediatr Endocrinol Diabetes Metab; 2007; 13(1):27-31. PubMed ID: 17493403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children.
    Dogan Y; Akarsu S; Ustundag B; Yilmaz E; Gurgoze MK
    Mediators Inflamm; 2006; 2006(1):59206. PubMed ID: 16864906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children.
    Zorena K; Myśliwska J; Myśliwiec M; Balcerska A; Hak Ł; Lipowski P; Raczyńska K
    Mediators Inflamm; 2007; 2007():92196. PubMed ID: 17641733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
    Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of electroretinography b-wave absolute latency, plasma levels of human basic fibroblast growth factor, vascular endothelial growth factor, soluble fatty acid synthase, and adrenomedullin in diabetic retinopathy.
    Zakareia FA; Alderees AA; Al Regaiy KA; Alrouq FA
    J Diabetes Complications; 2010; 24(3):179-85. PubMed ID: 19216096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum hyaluronic acid, tumor necrosis factor -alpha, vascular endothelial growth factor, NO, and Se levels in adult patients with Kashin-Beck disease].
    Li XY; Guo X; Wang LX; Geng D; Kang LL; Wang S; Wang ZF; Gu QS
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):941-4. PubMed ID: 17666321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiogenic activity and VEGF level in sera of diabetic patients with non-proliferative retinopathy].
    Skopiński P; Duda-Król B; Lipińska A; Sommer E; Chorostowska-Wynimko J; Demkow U; Szaflik J; Skopińska-Rózewska E; Struzik E
    Klin Oczna; 2004; 106(3 Suppl):421-3. PubMed ID: 15636222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy.
    Demircan N; Safran BG; Soylu M; Ozcan AA; Sizmaz S
    Eye (Lond); 2006 Dec; 20(12):1366-9. PubMed ID: 16284605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.